Stock Trading History of Hbm Bioventures Cayman Ltd
The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Hbm Bioventures Cayman Ltd since year 2005.
The trader's CIK number is 1232258.
At the time of this reporting, Hbm Bioventures Cayman Ltd is the 10% Owner of Micrus Endovascular Corp .
(stock ticker symbol MEND).
See this page for all insider trading activities at Micrus Endovascular Corp .
Note that in the past HBM BIOVENTURES CAYMAN LTD also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Hbm Bioventures Cayman Ltd since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-06-20
MEND
Micrus Endovascular Corp
Purchase
17,741
13.75
243,922
2008-06-19
MEND
Micrus Endovascular Corp
Purchase
3,459
13.58
46,966
2008-06-17
MEND
Micrus Endovascular Corp
Purchase
3,800
13.54
51,456
2008-06-05
MEND
Micrus Endovascular Corp
Purchase
30,000
12.19
365,700
2008-06-06
MEND
Micrus Endovascular Corp
Purchase
15,000
12.24
183,675
2008-02-15
MEND
Micrus Endovascular Corp
Purchase
7,700
13.92
107,199
2008-02-14
MEND
Micrus Endovascular Corp
Purchase
22,800
14.31
326,270
2008-02-14
MEND
Micrus Endovascular Corp
Purchase
23,600
14.13
333,449
2008-02-13
MEND
Micrus Endovascular Corp
Purchase
2,200
14.74
32,433
2008-02-13
MEND
Micrus Endovascular Corp
Purchase
50,100
14.54
728,629
2008-02-12
MEND
Micrus Endovascular Corp
Purchase
32,500
14.81
481,473
2008-02-13
MEND
Micrus Endovascular Corp
Purchase
7,700
14.39
110,815
2008-02-12
MEND
Micrus Endovascular Corp
Purchase
29,900
14.57
435,747
2007-08-22
MEND
Micrus Endovascular Corp
Sale
1,100
23.29
25,614
2007-08-17
MEND
Micrus Endovascular Corp
Sale
38,304
23.17
887,516
2007-08-17
MEND
Micrus Endovascular Corp
Sale
3,122
23.70
73,984
2007-08-20
MEND
Micrus Endovascular Corp
Sale
5,700
23.18
132,117
2007-08-20
MEND
Micrus Endovascular Corp
Sale
3,500
23.42
81,955
2007-08-21
MEND
Micrus Endovascular Corp
Sale
7,400
23.14
171,236
2007-08-21
MEND
Micrus Endovascular Corp
Sale
1,635
23.28
38,066
2007-02-07
MEND
Micrus Endovascular Corp
Sale
9,756
24.00
234,144
2007-02-06
MEND
Micrus Endovascular Corp
Sale
4,655
24.00
111,720
2007-02-05
MEND
Micrus Endovascular Corp
Sale
49,978
24.01
1,199,971
2007-01-31
MEND
Micrus Endovascular Corp
Sale
20,300
24.00
487,200
2007-02-02
MEND
Micrus Endovascular Corp
Sale
32,628
24.00
783,072
2007-02-09
MEND
Micrus Endovascular Corp
Sale
10,244
24.00
245,856
2005-03-16
ASPV
Aspreva Pharmaceuticals Corp
Purchase
32,215
12.83
413,415
2005-03-09
ASPV
Aspreva Pharmaceuticals Corp
Purchase
466,000
15.53
7,236,980
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Hbm Bioventures Cayman Ltd
(10% Owner of Micrus Endovascular Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
